CO2018010286A2 - Método para la purificación de proteínas - Google Patents

Método para la purificación de proteínas

Info

Publication number
CO2018010286A2
CO2018010286A2 CONC2018/0010286A CO2018010286A CO2018010286A2 CO 2018010286 A2 CO2018010286 A2 CO 2018010286A2 CO 2018010286 A CO2018010286 A CO 2018010286A CO 2018010286 A2 CO2018010286 A2 CO 2018010286A2
Authority
CO
Colombia
Prior art keywords
protein purification
antibodies
abstract
fragments
production
Prior art date
Application number
CONC2018/0010286A
Other languages
English (en)
Inventor
Richard Jones
Jonathan Symmons
Saskia Hocking
Original Assignee
Ucb Biopharma Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=58461345&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO2018010286(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Biopharma Sprl filed Critical Ucb Biopharma Sprl
Publication of CO2018010286A2 publication Critical patent/CO2018010286A2/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1864—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
    • B01D15/1871—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns placed in series
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/265—Adsorption chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
    • B01J20/20—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising free carbon; comprising carbon obtained by carbonising processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/282—Porous sorbents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00—Ion-exchange processes in general; Apparatus therefor
    • B01J47/014—Ion-exchange processes in general; Apparatus therefor in which the adsorbent properties of the ion-exchanger are involved, e.g. recovery of proteins or other high-molecular compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

RESUMEN La presente invención proporciona un método para la producción de anticuerpos o fragmentos de los mismos, con niveles reducidos de impurezas relacionadas a la reducción del anticuerpo.
CONC2018/0010286A 2016-04-01 2018-09-26 Método para la purificación de proteínas CO2018010286A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201605562 2016-04-01
PCT/EP2017/057685 WO2017167960A1 (en) 2016-04-01 2017-03-31 Method for protein purification

Publications (1)

Publication Number Publication Date
CO2018010286A2 true CO2018010286A2 (es) 2018-10-31

Family

ID=58461345

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2018/0010286A CO2018010286A2 (es) 2016-04-01 2018-09-26 Método para la purificación de proteínas

Country Status (18)

Country Link
US (1) US11014962B2 (es)
EP (1) EP3436173A1 (es)
JP (2) JP7012023B2 (es)
KR (1) KR102413808B1 (es)
CN (1) CN108883345B (es)
AU (1) AU2017242900B2 (es)
BR (1) BR112018068803A2 (es)
CA (1) CA3016847C (es)
CL (1) CL2018002689A1 (es)
CO (1) CO2018010286A2 (es)
EA (1) EA201892231A1 (es)
HK (1) HK1257713A1 (es)
IL (1) IL261560B (es)
MX (1) MX2018011435A (es)
MY (1) MY197993A (es)
RU (1) RU2737539C2 (es)
SG (1) SG11201807676UA (es)
WO (1) WO2017167960A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023136820A1 (en) * 2022-01-13 2023-07-20 Bayer Healthcare Llc Improved antibody manufacture

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5659795A (en) 1979-10-22 1981-05-23 Kanegafuchi Chem Ind Co Ltd Purification of nicotinic acid amide adenine dinucleotide
JP5808249B2 (ja) * 2008-10-20 2015-11-10 アッヴィ・インコーポレイテッド プロテインａアフィニティークロマトグラフィーを用いる抗体の単離および精製
US9096648B2 (en) * 2011-08-19 2015-08-04 Emd Millipore Corporation Methods of reducing level of one or more impurities in a sample during protein purification
SG11201402999UA (en) 2012-03-26 2014-07-30 Emd Millipore Corp Use of charged fluorocarbon compositions in methods for purification of biomolecules
EP2682168A1 (en) * 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
US9650411B2 (en) * 2012-08-07 2017-05-16 Kyowa Hakko Kirin Co., Ltd. Method of purifying protein
KR102351839B1 (ko) * 2013-03-21 2022-01-18 에보닉 오퍼레이션스 게엠베하 삼중 나선 단백질의 정제
EP3019521A1 (en) 2013-07-12 2016-05-18 EMD Millipore Corporation A method of determining virus removal from a sample containing a target protein using activated carbon
JP6141524B2 (ja) 2013-07-12 2017-06-07 メルク パテント ゲーエムベーハー 活性炭を用いた標的タンパク質含有サンプルからのフラグメントの除去
CN104546715B (zh) 2014-12-22 2018-01-16 蓝佳堂生物医药（福建）有限公司 一种用于上呼吸道感染的复合抗体口腔喷剂及其制备方法

Also Published As

Publication number Publication date
JP2019512255A (ja) 2019-05-16
IL261560A (en) 2018-10-31
KR20180131599A (ko) 2018-12-10
US11014962B2 (en) 2021-05-25
SG11201807676UA (en) 2018-10-30
CN108883345B (zh) 2022-09-13
CA3016847C (en) 2023-12-19
CA3016847A1 (en) 2017-10-05
EP3436173A1 (en) 2019-02-06
RU2737539C2 (ru) 2020-12-01
WO2017167960A1 (en) 2017-10-05
MY197993A (en) 2023-07-25
KR102413808B1 (ko) 2022-06-29
HK1257713A1 (zh) 2019-10-25
IL261560B (en) 2021-06-30
RU2018138445A (ru) 2020-05-12
JP2022036993A (ja) 2022-03-08
BR112018068803A2 (pt) 2019-01-22
AU2017242900A1 (en) 2018-10-04
AU2017242900B2 (en) 2022-07-28
JP7012023B2 (ja) 2022-01-27
EA201892231A1 (ru) 2019-03-29
MX2018011435A (es) 2019-01-10
US20190153028A1 (en) 2019-05-23
RU2018138445A3 (es) 2020-07-07
CL2018002689A1 (es) 2018-11-23
CN108883345A (zh) 2018-11-23

Similar Documents

Publication Publication Date Title
CL2021000630A1 (es) Métodos para producir un anticuerpo anti-c5 (divisional de la solicitud no. 201701585)
CL2020003409A1 (es) Moléculas de unión específicas para cd73 y métodos de fabricación de las mismas (divisional de la solicitud no. 201701154)
EA202092435A2 (ru) Моноклональные антитела против bcma
DOP2018000181A (es) Terapias de combinación para enfermedades malignas hematológicas con anticuerpos anti-cd38 e inhibidores de survivina
CO2019009365A2 (es) Anticuerpos anti-lag3
MX2018015592A (es) Anticuerpos inhibidores de puntos de control biespecificos.
ECSP17042921A (es) Anticuerpos anti-cd38 para el tratamiento de la leucemia mieloide aguda
CL2017000545A1 (es) Anticuerpos anti-her2 e inmunoconjugados
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
BR112016019871A2 (pt) anticorpos anti-cd38 para o tratamento de leucemia linfoblástica aguda
UA117289C2 (uk) Мультиспецифічне антитіло
EA201691610A1 (ru) Анти-jagged1 антитела и способы применения
EA201691367A1 (ru) Кристаллические формы дималеата афатиниба
EA201792612A1 (ru) 6-аминохинолин-3-карбонитрилы в качестве модуляторов cot
GEP20227382B (en) Anti-coagulation factor xi antibodies
EA201890340A1 (ru) Моноклональное антитело-ингибитор фактора xiia
CL2017000087A1 (es) Un proceso novedoso para la purificación de rhu-gcsf
BR112017022073A2 (pt) método para purificação de proteína
CY1122728T1 (el) Αντισωματα εναντι hpa-1a
NZ733454A (en) Treatment of autoimmune disorders with cd154 antibodies
EA201692482A1 (ru) Способы лечения заболеваний антителами, которые связывают рецептор колониестимулирующего фактора 1 (csf1r)
CL2017001633A1 (es) Método de manufactura de proteína.
FR3058143B1 (fr) Nanocorps anti-tau
EA201792527A1 (ru) Лечение зуда
CO2018010286A2 (es) Método para la purificación de proteínas